Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical TrialAdam B. Weiner, Leonard S. Marks, Mamdouh Aker et al.|JCO Precision Oncology|2025Cited by 3